CKD, Diabetes, and Albuminuria: Keeping Kidney-Protective Therapy on Board Despite Hyperkalemia
Ellie Kelepouris, MD, FACP, FAHA
Pauline A. Swift, PhD
Potassium Binders to Optimize GDMT Therapy in HFrEF
Nihar R. Desai, MD, MPH
Differentiating Oral Potassium Binders: Mechanism, Onset, and Sodium Load
James Burton, DM, FRCP
Hyperkalemia as a Barrier to GDMT: Why “Stopping GDMT” Is Often the Wrong Reflex
The Potassium Shift: Individualizing Hyperkalemia Management With Modern Oral Potassium Binders
The Binder Selection Playbook: Matching the Right Strategy to the Right Patient
A Case-Based Discussion on Managing Adult Patients With C3G or IC-MPGN in the Era of Complement Inhibition
Kenar D. Jhaveri, MD
Shikha Wadhwani MD, MS
From Lab Alert to Action Plan: Monitoring Potassium Without Undermining Cardiorenal Protection
Personalized Treatment Strategies for Hyperkalemia: Bridging Evidence and Clinical Practice Needs
The Edema Question: Selecting a Potassium Binder in Patients With HF or Congestion
Navigating KDIGO Guidance in IgAN
Jonathan Barratt, MD, PhD
Jörg Latus, MD
Mechanisms Matter! Optimizing Proteinuria Reduction In IgAN
Chee Kay Cheung, MBChB, MRCP, PhD
Unmasking IgAN: Achieving Earlier Diagnosis
An De Vriese, MD, PhD
The Hidden Danger of IgAN: Pathogenesis and Unmet Needs
Decoding IgA Nephropathy: From Suspicion to Solution
The Future of IgAN Care